Form 8-K - Current report:
SEC Accession No. 0001193125-23-116108
Filing Date
2023-04-26
Accepted
2023-04-25 21:53:25
Documents
15
Period of Report
2023-04-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d466902d8k.htm   iXBRL 8-K 35420
2 EX-99.1 d466902dex991.htm EX-99.1 15941
7 GRAPHIC g466902g0426041520054.jpg GRAPHIC 5594
  Complete submission text file 0001193125-23-116108.txt   228583

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclx-20230425.xsd EX-101.SCH 4113
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclx-20230425_def.xml EX-101.DEF 13653
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclx-20230425_lab.xml EX-101.LAB 22575
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclx-20230425_pre.xml EX-101.PRE 14621
9 EXTRACTED XBRL INSTANCE DOCUMENT d466902d8k_htm.xml XML 5405
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 23846612
SIC: 2836 Biological Products, (No Diagnostic Substances)